Xeris Biopharma Holdings
XERS
XERS
201 hedge funds and large institutions have $423M invested in Xeris Biopharma Holdings in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 79 increasing their positions, 58 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
201
Holders Change
+2
Holders Change %
+1.01%
% of All Funds
2.7%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
27
Increased
79
Reduced
58
Closed
24
Calls
$1.02M
Puts
$384K
Net Calls
+$634K
Net Calls Change
-$1.27M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$45.8M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$14.4M |
| 3 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
$7.45M |
| 4 |
D.E. Shaw & Co
New York
|
$17.9M |
| 5 |
BlackRock
New York
|
$53.9M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
JPMorgan Chase & Co
New York
|
$4.82M |
| 3 |
Invesco
Atlanta,
Georgia
|
$403K |
| 4 |
Jane Street
New York
|
$146K |
| 5 |
Morgan Stanley
New York
|
$17M |
